ArticleMolecular cancer therapeutics2008

Differential bortezomib sensitivity in head and neck cancer lines corresponds to proteasome, nuclear factor-kappaB and activator protein-1 related mechanisms.

Zhong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.